Amgen

7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Sat, 01/14/12 - 11:32 am
Amgen
Ariad Pharmaceuticals
Biogen
Celgene
Gilead Sciences
Vertex Pharmaceuticals
30% Safe Upside For Merck, Amgen
Seeking Alpha
Thu, 01/12/12 - 10:54 am
Amgen
Merck
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Celldex
Amgen
Bristol-Myers Squibb
Dendreon
Seattle Genetics
Exelixis
Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks
Yahoo/AP
Tue, 01/10/12 - 09:05 am
Amgen
Pharma CEOs
Robert Bradway
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Abbott Laboratories
Amgen
Biogen Idec
Gilead
Celgene
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
ETFs
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy
Mon, 01/9/12 - 10:10 am
JPMorgan
IPOs
Amgen
FDA
innovation
The Magic Formula for Biotech
Motley Fool
Sun, 01/8/12 - 12:50 pm
Gilead
Amgen
Is Amgen's Stock Cheap by the Numbers?
Motley Fool
Sun, 01/8/12 - 12:48 pm
Amgen
Amgen, big biotechs poised for big year of deals, analysts say
Fierce Pharma
Fri, 01/6/12 - 01:37 pm
Amgen
biotech
M&A
Celgene
Will Amgen Buy Out Biogen Idec?
Seeking Alpha
Thu, 01/5/12 - 12:39 pm
Biogen Idec
Amgen
M&A
6 'Coiled Spring' Biotech Stocks To Consider In 2012
Seeking Alpha
Tue, 01/3/12 - 12:48 pm
Amgen
Biogen Idec
Bristol-Myers Squibb
Celgene
Merck
Oncothyreon
Teva Pharmaceuticals
Vical
Seattle Genetics
Is Amgen a Buffett Stock?
Motley Fool
Fri, 12/30/11 - 01:28 pm
Amgen
Warren Buffett
Amgen: Xgeva panel review scheduled for February
Yahoo/AP
Thu, 12/29/11 - 10:35 pm
Amgen
Xgeva
advisory panel
FDA
prostate cancer
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Amgen
Biogen Idec
Celgene
Gilead
Pharmasset
Alexion
Regeneron
Recent Performance Review Of 5 Large Cap Biotech Equities
Seeking Alpha
Tue, 12/27/11 - 12:36 pm
Alexion
Amgen
Biogen Idec
Celgene
Gilead
Merck
Pfizer
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
Big Pharma buybacks, spinoffs cater to investors
Fierce Pharma
Fri, 12/23/11 - 08:50 am
spin-offs
stock buybacks
investors
Pfizer
GSK
Abbott Laboratories
AstraZeneca
Amgen
Teva Pharmaceuticals
Merck
4 Biotech Stocks With Consistently Rising EPS
Seeking Alpha
Thu, 12/22/11 - 09:16 am
Amgen
Biogen Idec
Gilead
Illumina
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
Yahoo
Mon, 12/19/11 - 04:04 pm
Amgen
Watson
biosimilars
cancer
oncology

Pages